Enrofloxacin, identified by its CAS number 162301-05-5, is a synthetic fluoroquinolone antibiotic primarily used in veterinary medicine. It exhibits broad-spectrum antibacterial activity against a variety of Gram-negative and some Gram-positive bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and transcription. Enrofloxacin is characterized by its high lipophilicity, which enhances its penetration into bacterial cells. The compound is typically administered orally or via injection and is known for its rapid absorption and distribution in tissues. It is important to note that enrofloxacin is not approved for use in food-producing animals in some regions due to concerns about antibiotic resistance and potential residues in food products. Side effects may include gastrointestinal disturbances and, in rare cases, effects on cartilage development in young animals. As with all antibiotics, appropriate use is crucial to minimize the development of resistance and ensure efficacy in treating bacterial infections.

ECENOFLOXACIN

162301-05-5: Ecenofloxacin [INN], (+)-7-((1R,5S,6S)-6-Amino-1-methyl-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, Unii-3613Zy362L, 1,8-Naphthyridine-3-carboxylic acid, 7-((1R,5S,6S)-6-amino-1-methyl-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, rel-( )-, 7-[(1R,5S,6S)-6-amino-1-methyl-3-azabicyclo[3.2.0]hept-3-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid,  Ecenofloxacin

(1R,5S,6S)-6-Amino-1-methyl-3-azabicyclo[3.2.0]heptan-3-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine 3 carboxylic acid is a novel fluoroquinolone antimicrobial agent that has been shown to be an effective treatment for infectious diseases caused by Gram positive and Gram negative bacteria. This molecule has ester linkages that are easily hydrolyzed and biodegraded in the environment. The drug was developed as an oral prodrug with a reconstituted formulation of cyclopropyl amide, which is stable in water and can be administered orally. (1R,5S,6S)-6-Amino-1-methyl-3-(azabicyclo[3.2.0]heptan 3 y

CAS 162301-05-5: ECENOFLOXACIN

7-[(1R,5S,6S)-6-Amino-1-Methyl-3-Azabicyclo[3.2.0]Heptan-3-Yl]-1-Cyclopropyl-6-Fluoro-4-Oxo-1,8-Naphthyridine-3-Carboxylic Acid

Ref: 3D-FA103560